Cacto Health Secures $3M to Empower Breast Cancer Patients with Innovative Lymphedema Monitoring Technology

Cacto Health is excited to announce that we have successfully raised $3,000,000 in new funding—a milestone that reinforces our commitment to revolutionizing patient care through innovative medical technology. As a dynamic spin-out from the Biomedical Design Novo Nordisk Foundation Fellowship Program at Aarhus University, we have leveraged cutting-edge research, design thinking, and extensive clinical expertise to develop a platform and device dedicated to empowering breast cancer patients. Our focus is on the early detection and home monitoring of lymphedema, ensuring that users can perform reliable measurements digitally from the comfort of their own homes. This funding will drive the final stages of device development, bolster our research initiatives, and enhance our digital solutions, allowing us to scale our validated approach even further. At Cacto Health, our approach combines the principles of co-creation and user-centric design with robust technical and clinical know-how. We deeply value the insights of our users and customers, integrating their feedback directly into our development process to create a product that is as intuitive as it is groundbreaking. Working out of The Kitchen at Aarhus University’s Start-up Hub, we are at the heart of a vibrant ecosystem that nurtures innovative ideas and fosters strong collaborative ties with industry professionals. This new round of funding not only accelerates our technical advancements but also strengthens our mission to improve quality of life through better health monitoring and care. We are eager to connect with new partners and professionals who share our vision for transforming healthcare, and we remain committed to creating a future where reliable, user-friendly care is accessible to all.